WQ84395 (e) Wedi’i gyflwyno ar 31/01/2022

Faint o bobl sydd wedi cael eu trin â chemotherapi ymwthiol hyperthermig yng Nghymru, a faint sydd wedi cael eu cyfeirio at Loegr, ym mhob blwyddyn ers 2017?

Wedi'i ateb gan Y Gweinidog Iechyd a Gwasanaethau Cymdeithasol | Wedi'i ateb ar 10/02/2022

The Welsh Health Specialised Services Committee (WHSSC) is responsible for commissioning Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy on behalf of health boards in Wales. Its commissioning policies can be found at:

https://whssc.nhs.wales/commissioning/whssc-policies/cancer/hyperthermic-intraperitoneal-chemotherapy-hipec-and-cytoreductive-surgery-for-treatment-of-pseudomyxoma-peritonei-commissioning-policy-cp02-september-2015/

https://whssc.nhs.wales/commissioning/whssc-policies/cancer/cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-for-peritoneal-carcinomatosis-and-pseudomyxoma-peritonei-policy-position-statement-pp90-september-2015/

The Welsh Government does not routinely collect data on the number of patients referred for this technique. The technique is not available in Wales.